Prevalence of complementary and alternative medicine use in brain tumor patients at King Abdulaziz University Hospital, Jeddah, Saudi Arabia.


Journal

Saudi medical journal
ISSN: 1658-3175
Titre abrégé: Saudi Med J
Pays: Saudi Arabia
ID NLM: 7909441

Informations de publication

Date de publication:
Jun 2020
Historique:
entrez: 11 6 2020
pubmed: 11 6 2020
medline: 27 10 2020
Statut: ppublish

Résumé

To determine the prevalence and types of complementary and alternative medicine (CAM) being utilized and the possible factors that prompted the use of CAM in patients with brain tumors. Methods: The study conducted was a questionnaire-based, cross-sectional study of patients diagnosed with brain tumors at King Abdulaziz University Hospital (KAUH), Jeddah, Saudi Arabia from January 2011 to May 2018. Patients with primary and secondary brain tumors, were included. Our questionnaire was conducted via phone interviews after obtaining patient consent.  Results: A total of 72 patients were included. The mean age of the participants was 45.89 (±16.52) years. We found that education level significantly affected the use of CAM. Fewer users of CAM held bachelor's degree and patients with lower degrees used CAM more frequently (p=0.027). The most frequent types of CAM were Zamzam (holy water) and Ruqya (Quran reading). Family members were the most frequent source of information about the use of CAM (81.6%).  Conclusion: Education level has a significant effect on CAM use. Gender plays a role in the type of CAM used. Future research should focus on the adverse effects of some CAM therapies, how effective CAM therapies are, and the effect CAM may play in delaying patients from seeking medical advice.

Identifiants

pubmed: 32518928
doi: 10.15537/smj.2020.625102
pmc: PMC7502940
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

614-621

Références

JAMA Oncol. 2018 Oct 1;4(10):1375-1381
pubmed: 30027204
Integr Cancer Ther. 2005 Dec;4(4):274-86
pubmed: 16282504
Drug Metab Pharmacokinet. 2002;17(5):467-74
pubmed: 15618698
JAMA. 1998 Nov 11;280(18):1569-75
pubmed: 9820257
Evid Based Complement Alternat Med. 2015;2015:182475
pubmed: 26770251
J Infect Dis. 2017 Jun 1;215(11):1702-1705
pubmed: 28387845
Gynecol Oncol. 2002 Mar;84(3):363-7
pubmed: 11855870
PLoS One. 2018 Mar 7;13(3):e0193686
pubmed: 29513724
J Cancer Surviv. 2016 Oct;10(5):850-64
pubmed: 26920872
Evid Based Complement Alternat Med. 2016;2016:2067095
pubmed: 27239207
J Urol. 2019 Oct;202(4):689-695
pubmed: 31091175
BMC Complement Altern Med. 2015 Apr 01;15:102
pubmed: 25887047
Euro Surveill. 2014 Jun 12;19(23):
pubmed: 24957745
Ann Oncol. 2005 Apr;16(4):655-63
pubmed: 15699021
J Clin Oncol. 2005 Aug 20;23(24):5805-13
pubmed: 16027437
Evid Based Complement Alternat Med. 2016;2016:4382687
pubmed: 27528880
J Family Community Med. 2000 May;7(2):17-25
pubmed: 23008618
J Altern Complement Med. 2012 Nov;18(11):1045-9
pubmed: 22906212
Ann Saudi Med. 2013 May-Jun;33(3):282-9
pubmed: 23793433
Complement Ther Clin Pract. 2019 May;35:33-47
pubmed: 31003679
BMC Complement Altern Med. 2018 Mar 12;18(1):88
pubmed: 29530034
Neuro Oncol. 2016 Feb;18(2):252-60
pubmed: 26289592
Curr Neurol Neurosci Rep. 2008 May;8(3):264-8
pubmed: 18541122
Rev Sci Tech. 2010 Dec;29(3):663-9
pubmed: 21309464
J Pharm Pharm Sci. 2001 May-Aug;4(2):176-84
pubmed: 11466175
Complement Ther Med. 2000 Mar;8(1):32-6
pubmed: 10812758
Ann Saudi Med. 2008 Jan-Feb;28(1):4-10
pubmed: 18299652
Integr Cancer Ther. 2018 Jun;17(2):371-379
pubmed: 29025275
J Clin Oncol. 2000 Jul;18(13):2505-14
pubmed: 10893280
Neuro Oncol. 2008 Feb;10(1):61-72
pubmed: 17993635
JAMA Oncol. 2016 Sep 1;2(9):1170-6
pubmed: 27243607
J Clin Oncol. 2004 Jun 15;22(12):2489-503
pubmed: 15197212
Br J Nutr. 2003 Feb;89(2):189-200
pubmed: 12575903

Auteurs

Abdulgadir Atteiah (A)

Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. E-mail.. abdulgadiratteiah@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH